The Premium Business Information Source™
Report title:
ADELCO-COMPANY INSIGHT
from
TF Market Research
13 page report published Nov 19, 2008
Price
$480.00
available for immediate download
This report is also available for purchase on a
per-page basis
.
Report Overview
Purchase by Section
Search Inside
...ADELCO is a manufacturer of dyes and allied chemical s. The company was established in #### with an aim to maintain a strict control of hygiene and quality factors in both the producti on process and services it offers. ADELCO's most important activity is the production of modern Pha rmaceutical Specialities and toiletry cosmetics. Its cosmetics are scientifically manufac tured and are suitable for all the family, offering the finest quality and excellent results. Its pharmaceutical products include: Antidepressants, Tranquilisers, Neuroleptic, Cardiovascular, Coronary Vasodilator, Antihypertensive, Tranquiliser - Anticholinergic, Antiinflamatory, Antihistamine, etc. ADLECO has also been involved in the manufacturing of products for various companies known in the industry of pharmaceut icals and cosmetics such as: Parke Davis, Le Petti, Pfrimmer, Daiichi, Cox, Revlon, Perlier, English Leather Cosmed, Isis and Ashvik. LSA. Life Science Analytics,...
Source:
LIFE SCIENCE ANALYTICS
Author:
HARINATHA, G.
Company:
ADELCO
Geographic Regions:
EUROPE, GREECE, SOUTHERN EUROPE
Non-Billable Page Numbers:
2
Sections
Title
Starting Page
Number of Pages
Company Information
1
1
Adelco [NonUS -- Symbol : Private]
1
1
Formation Date: 1934
1
1
Business Summary
1
1
Product Glance
3
1
Trial Phase
3
1
No of Products
3
1
Diseasehub Classification
3
1
Disease Hub
3
1
Product Summary
4
1
Products
4
1
Condition Treated
4
2
Trial Phase Source Partner
4
2
Product Details
5
1
1. Depramine Disease Hub Description
5
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 2. Minitran Disease Hub Description
5
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 3. Notorium Disease Hub Description
5
1
Therapeutic Indication Drug Class
5
2
Current Trial Trial Details Last Updated 4. Saturnil Disease Hub Description
6
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 5. Stedon Disease Hub Description
6
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 6. Solidon Disease Hub Description
6
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 7. Procardol Disease Hub Description
6
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 8. Adezan Disease Hub Description
6
1
Current Trial Trial Details Last Updated 9. Mesonex Disease Hub Description
7
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 10. Neourizine Disease Hub Description
7
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 11. Normolose Disease Hub Description
7
1
Therapeutic Indication Drug Class Current Trial M Trial Details Last Updated 12. Normolose-H Disease Hub Description
7
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 13. Distedon Disease Hub Description
7
1
Therapeutic Indication Current Trial Trial Details Last Updated 14. Butazinal Disease Hub Description
8
1
Therapeutic Indication Current Trial Trial Details Last Updated 15. Istamex Disease Hub Description
8
1
Therapeutic Allergy Indication Drug Class Current Trial M Trial Details Last Updated 16. Bronchotussine Disease Hub
8
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 17. Vicholex Disease Hub Description
8
1
Therapeutic Indication Current Trial Trial Details Last Updated 18. Adelcort
8
1
Disease Hub Description
9
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 19. Dermol Disease Hub Description
9
1
Therapeutic Indication Current Trial Trial Details Last Updated 20. Dermolate Disease Hub Description
9
1
Therapeutic Skin Indication Drug Class Topical Current Trial M Trial Details Presently Last Updated 9/25/2008 21.
9
1
Therapeutic Skin Indication Drug Class Current Trial M Trial Details Last Updated 22. Anaboline Depot Disease Hub
9
1
Therapeutic
9
2
Indication Drug Class Current Trial Trial Details Last Updated 23. Neolut Disease Hub Description
10
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 24. Panto B+C Disease Hub Description
10
1
Therapeutic Indication Current Trial Trial Details Last Updated 25. C- Rutine Disease Hub Description
10
1
Therapeutic Indication Current Trial Trial Details Last Updated 26. Filicine Disease Hub Description
10
1
Therapeutic Indication Current Trial Trial Details Last Updated 27. Paroticin Disease Hub Description
10
1
Indication Current Trial Trial Details Last Updated 28. Oradin Disease Hub Description
11
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 30. Adelcopen Disease Hub Description
11
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 31. Acinic Disease Hub Description
11
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 32. Ponotex Disease Hub Description
11
1
Therapeutic Indication Current Trial Trial Details Last Updated 33. Salopyrine Disease Hub Description
12
1
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated
12
2
Enter the keyword(s) which you would like to search for within this document and click "Search"
TF Market Research
TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.
Price: $480.00
Questions about
this research?
Send to a friend